SCHEMBL14003757

SCHEMBL14003757

CC(C)c1cccc(C(C)C)c1N1C(=O)c2cccc3c(Oc4ccc(N)cc4)ccc(c23)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 3/20 0.56
▸ DPP4 P27487 3/20 0.44
▸ MCL1 Q07820 7/20 0.44
▸ BCL2 P10415 6/20 0.44
▸ BCL2L1 Q07817 4/20 0.44
▸ NR1H2 P55055 1/20 0.43
▸ NR1H3 Q13133 1/20 0.43
▸ PRMT1 Q99873 1/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ MAPT P10636 3/20 0.41
▸ HTT P42858 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ PABPC1 P11940 1/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ SMARCA2 P51531 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3284746 0.92 MCL1 (0.52) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL14003739 0.90 ANPEP (0.45) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL14003719 0.89 ANPEP (0.56) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL14003729 0.87 ANPEP (0.46) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL14003750 0.86 ANPEP (0.42) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL14003717 0.85 ANPEP (0.44) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL15995450 0.84 ANPEP (0.50) ANPEPDPP4NR1H2NR1H3PRMT1
SCHEMBL1518018 0.84 DPP4 (0.42) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL14003713 0.84 ANPEP (0.43) ANPEPDPP4MCL1BCL2BCL2L1
SCHEMBL17439429 0.84 ANPEP (0.48) ANPEPDPP4MCL1BCL2NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917311-B1 Rylene based multiple chromophores BASF SE (DE) 2015-09-23 — — EP disclosed
US-8501948-B2 Multiple chromophores based on rylene BASF AKTIENGESELLSCHAFT (DE) 2013-08-06 — — US disclosed
US-8501948-B2 Multiple chromophores based on rylene BASF AKTIENGESELLSCHAFT (DE) 2013-08-06 — — US disclosed
US-20080287678-A1 Multiple Chromophores Based on Rylene BASF AKTIENGESELLSCHAFT (DE) 2008-11-20 — — US disclosed
US-20080287678-A1 Multiple Chromophores Based on Rylene BASF AKTIENGESELLSCHAFT (DE) 2008-11-20 — — US disclosed
WO-2007014902-A2 MULTIPLE CHROMOPHORES BASED ON RYLENE BASF SE (DE) 2007-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287678-A1 Multiple Chromophores Based on Rylene TDO2, PPOX, NPY1R ANPEP 2170/4885DPP4 3749/4885MCL1 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback